CoVac-1, a new vaccine against SARS-CoV-2, induced T-cell immune responses in 93 percent of patients with B-cell deficiencies. from Medindia Health News https://ift.tt/SX2VWHt
No comments
Thanks for comment via will connect you within 24 hours.